AAAAAA
Results:
1-24
|
Results: 24
Authors:
WIESEMANN HG
STEINKAMP G
RATJEN F
BAUERNFEIND A
PRZYKLENK B
DORING G
VONDERHARDT H
Citation: Hg. Wiesemann et al., PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF AEROSOLIZED TOBRAMYCIN FOR EARLY TREATMENT OF PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS, Pediatric pulmonology, 25(2), 1998, pp. 88-92
Authors:
ULRICH M
HERBERT S
BERGER J
BELLON G
LOUIS D
MUNKER G
DORING G
Citation: M. Ulrich et al., LOCALIZATION OF STAPHYLOCOCCUS-AUREUS IN INFECTED AIRWAYS OF PATIENTSWITH CYSTIC-FIBROSIS AND IN A CELL-CULTURE MODEL OF STAPHYLOCOCCUS-AUREUS ADHERENCE, American journal of respiratory cell and molecular biology, 19(1), 1998, pp. 83-91
Authors:
DANIELSEN L
BALSLEV E
DORING G
HOIBY N
MADSEN SM
AGREN M
THOMSEN HK
FOS HHS
WESTH H
Citation: L. Danielsen et al., ULCER BED INFECTION - REPORT OF A CASE OF ENLARGING VENOUS LEG ULCER COLONIZED BY PSEUDOMONAS-AERUGINOSA, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 106(7), 1998, pp. 721-726
Authors:
WORLITZSCH D
HERBERTH G
ULRICH M
DORING G
Citation: D. Worlitzsch et al., CATALASE, MYELOPEROXIDASE AND HYDROGEN-PEROXIDE IN CYSTIC-FIBROSIS, The European respiratory journal, 11(2), 1998, pp. 377-383
Authors:
DORING G
Citation: G. Doring, STAPHYLOCOCCUS-AUREUS IN CYSTIC-FIBROSIS - IMPLICATIONS FOR PROGNOSISAND TREATMENT, Pediatric pulmonology, 1997, pp. 235-236
Authors:
DORING G
Citation: G. Doring, ANTIINFLAMMATORY THERAPY, Pediatric pulmonology, 1997, pp. 271-272
Authors:
BELLON G
MICHELCALEMARD L
THOUVENOT D
JAGNEAUX V
POITEVIN F
MALCUS C
ACCART N
LAYANI MP
AYMARD M
BERNON H
BIENVENU J
COURTNEY M
DORING G
GILLY B
GILLY R
LAMY D
LEVREY H
MOREL Y
PAULIN C
PERRAUD F
RODILLON L
SENE C
SO S
TOURAINEMOULIN F
SCHATZ C
PAVIRANI A
Citation: G. Bellon et al., AEROSOL ADMINISTRATION OF A RECOMBINANT ADENOVIRUS EXPRESSING CFTR TOCYSTIC-FIBROSIS PATIENTS - A PHASE-I CLINICAL-TRIAL, Human gene therapy, 8(1), 1997, pp. 15-25
Authors:
DORING G
Citation: G. Doring, THE ROLE OF PROTEINASES FROM PSEUDOMONAS-AERUGINOSA AND POLYMORPHONUCLEAR LEUKOCYTES IN CYSTIC-FIBROSIS, Medicamentos de actualidad, 33(6), 1997, pp. 393-403
Authors:
HERBERT S
WORLITZSCH D
DASSY B
BOUTONNIER A
FOURNIER JM
BELLON G
DALHOFF A
DORING G
Citation: S. Herbert et al., REGULATION OF STAPHYLOCOCCUS-AUREUS CAPSULAR POLYSACCHARIDE TYPE-5 - CO2 INHIBITION IN-VITRO AND IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 431-438
Authors:
DORING G
JANSEN S
NOLL H
GRUPP H
FRANK F
BOTZENHART K
MAGDORF K
WAHN U
Citation: G. Doring et al., DISTRIBUTION AND TRANSMISSION OF PSEUDOMONAS-AERUGINOSA AND BURKHOLDERIA-CEPACIA IN A HOSPITAL WARD, Pediatric pulmonology, 21(2), 1996, pp. 90-100
Authors:
DORING G
Citation: G. Doring, MECHANISMS OF AIRWAY INFLAMMATION IN CYSTIC-FIBROSIS, Pediatric allergy and immunology, 7, 1996, pp. 63-66
Authors:
VOGELMEIER C
DORING G
Citation: C. Vogelmeier et G. Doring, NEUTROPHIL PROTEINASES AND RHDNASE THERAPY IN CYSTIC-FIBROSIS, The European respiratory journal, 9(11), 1996, pp. 2193-2195
Authors:
DANIELSEN L
WESTH H
BALSELV E
ROSDAHL VT
DORING G
Citation: L. Danielsen et al., PSEUDOMONAS-AERUGINOSA EXOTOXIN-A ANTIBODIES IN RAPIDLY DETERIORATINGCHRONIC LEG ULCERS, Lancet, 347(8996), 1996, pp. 265-265
Authors:
DORING G
PFEIFFER C
WEBER U
MOHRPENNERT A
DORNER F
Citation: G. Doring et al., PARENTERAL APPLICATION OF A PSEUDOMONAS-AERUGINOSA FLAGELLA VACCINE ELICITS SPECIFIC ANTI-FLAGELLA ANTIBODIES IN THE AIRWAYS OF HEALTHY-INDIVIDUALS, American journal of respiratory and critical care medicine, 151(4), 1995, pp. 983-985
Authors:
BAUMBACH A
BRAUN U
DORING G
HAASE KK
VOELKER W
KARSCH KR
Citation: A. Baumbach et al., DOUBLE-BLIND COMPARISON OF THE ACUTE EFFECTS OF 2 RELEVANT DOSES OF ORAL NICORANDIL ON CENTRAL HEMODYNAMICS, LEFT-VENTRICULAR FUNCTION, ANDMYOCARDIAL-CONTRACTILITY, Cardiovascular drugs and therapy, 9, 1995, pp. 213-220
Authors:
DORING G
WORLITZSCH D
Citation: G. Doring et D. Worlitzsch, REACTIVE OXYGEN COMPOUNDS AND ARACHIDONIC -ACID METABOLITES OF POLYMORPHONUCLEAR LEUKOCYTES, Immunitat und Infektion, 23(5), 1995, pp. 148-157
Authors:
DORING G
FRANK F
BOUDIER C
HERBERT S
FLEISCHER B
BELLON G
Citation: G. Doring et al., CLEAVAGE OF LYMPHOCYTE SURFACE-ANTIGENS CD2, CD4, AND CD8 BY POLYMORPHONUCLEAR LEUKOCYTE ELASTASE AND CATHEPSIN-G IN PATIENTS WITH CYSTIC-FIBROSIS, The Journal of immunology, 154(9), 1995, pp. 4842-4850
Authors:
DORING G
KROGHJOHANSEN H
WEIDINGER S
HOIBY N
Citation: G. Doring et al., ALLOTYPES OF ALPHA(1)-ANTITRYPSIN IN PATIENTS WITH CYSTIC-FIBROSIS, HOMOZYGOUS AND HETEROZYGOUS FOR DELTAF508, Pediatric pulmonology, 18(1), 1994, pp. 3-7
Authors:
WOLZ C
LEHMANN R
VASIL ML
BISCHOFF R
DORING G
Citation: C. Wolz et al., A NEW EXTRACELLULAR PROTEIN OF PSEUDOMONAS-AERUGINOSA PA103 REGULATEDBY REGA, Microbiology, 140, 1994, pp. 1755-1761
Authors:
DORING G
Citation: G. Doring, THE ROLE OF NEUTROPHIL ELASTASE IN CHRONIC INFLAMMATION, American journal of respiratory and critical care medicine, 150(6), 1994, pp. 190000114-190000117
Authors:
ELBANAYOSY A
DORING G
KORNER MM
POSIVAL H
KORTKE H
HARTMANN D
KORFER R
Citation: A. Elbanayosy et al., NEW ASPECTS IN THE MANAGEMENT OF POSTOPER ATIVE LOW-OUTPUT SYNDROME, Zeitschrift fur Kardiologie, 83, 1994, pp. 69-74
Authors:
SILVA FDE
BARANOV V
BARBERO GJ
BRODY SL
DORING G
GOTZ M
HODSON ME
HOIBY N
KAPRANOV N
KNOWLES MR
LANNEFORS L
MASTELLA G
NOIRCLERC M
QUINTON PM
SHALE DJ
SHEPHERD R
WIILIAMSON R
WEIBEL M
BOULYJENKOV V
Citation: Fde. Silva et al., THERAPEUTIC APPROACHES TO CYSTIC-FIBROSIS - MEMORANDUM FROM A JOINT WHO ICF(M)A MEETING, Bulletin of the World Health Organization, 72(3), 1994, pp. 341-352
Authors:
WOLZ C
HOHLOCH K
OCAKTAN A
POOLE K
EVANS RW
ROCHEL N
ALBRECHTGARY AM
ABDALLAH MA
DORING G
Citation: C. Wolz et al., IRON RELEASE FROM TRANSFERRIN BY PYOVERDIN AND ELASTASE FROM PSEUDOMONAS-AERUGINOSA, Infection and immunity, 62(9), 1994, pp. 4021-4027
Authors:
DORING G
HORZ M
ORTELT J
GRUPP H
WOLZ C
Citation: G. Doring et al., MOLECULAR EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA IN AN INTENSIVE-CAREUNIT, Epidemiology and infection, 110(3), 1993, pp. 427-436
Risultati:
1-24
|